+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acute Coronary Syndrome - Market Analysis, Trends, and Forecasts

  • ID: 1227823
  • Report
  • 111 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Amgen
  • Astrazeneca Plc
  • Daiichi Sankyo Co., Ltd.
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • Momenta Pharmaceuticals
  • MORE
Acute Coronary Syndrome market worldwide is projected to grow by US$37.2 Billion, driven by a compounded growth of 13.3%. Acute Coronary Syndrome, one of the segments analyzed and sized in this study, displays the potential to grow at over 13.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$63.8 Billion by the year 2025, Acute Coronary Syndrome will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$1.5 Billion to the region's size and clout in the next 5 to 6 years. Over US$1.2 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Acute Coronary Syndrome will reach a market size of US$3.5 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 17.1% over the next couple of years and add approximately US$9 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Amgen, Inc.
  • Astellas Pharma, Inc.
  • AstraZeneca PLC
  • Biological E. Ltd.
  • Daiichi Sankyo Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Momenta Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Recordati SpA
  • The Medicines Company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen
  • Astrazeneca Plc
  • Daiichi Sankyo Co., Ltd.
  • Eli Lilly and Company
  • Glaxosmithkline Plc
  • Momenta Pharmaceuticals
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Acute Coronary Syndrome Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Acute Coronary Syndrome Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Acute Coronary Syndrome Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Acute Coronary Syndrome Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

TABLE 4: United States Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025

TABLE 5: Acute Coronary Syndrome Market in the United States: A Historic Review in US$ Million for 2009-2017

CANADA

TABLE 6: Canadian Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025

TABLE 7: Canadian Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017

JAPAN

TABLE 8: Japanese Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 9: Acute Coronary Syndrome Market in Japan: Historic Sales Analysis in US$ Million for the Period 2009-2017

CHINA

TABLE 10: Chinese Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025

TABLE 11: Acute Coronary Syndrome Historic Market Analysis in China in US$ Million: 2009-2017

EUROPE

Market Facts & Figures

TABLE 12: European Acute Coronary Syndrome Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 13: Acute Coronary Syndrome Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 14: European Acute Coronary Syndrome Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

FRANCE

TABLE 15: Acute Coronary Syndrome Market in France: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 16: French Acute Coronary Syndrome Historic Market Scenario in US$ Million: 2009-2017

GERMANY

TABLE 17: Acute Coronary Syndrome Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025

TABLE 18: German Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017

ITALY

TABLE 19: Italian Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025

TABLE 20: Acute Coronary Syndrome Historic Market Analysis in Italy in US$ Million: 2009-2017

UNITED KINGDOM

TABLE 21: United Kingdom Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 22: Acute Coronary Syndrome Market in the United Kingdom: Historic Sales Analysis in US$ Million for the Period 2009-2017

SPAIN

TABLE 23: Spanish Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025

TABLE 24: Spanish Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017

RUSSIA

TABLE 25: Russian Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025

TABLE 26: Acute Coronary Syndrome Market in Russia: A Historic Review in US$ Million for 2009-2017

REST OF EUROPE

TABLE 27: Rest of Europe Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025

TABLE 28: Acute Coronary Syndrome Market in Rest of Europe in US$ Million: A Historic Review for the Period 2009-2017

ASIA-PACIFIC

TABLE 29: Asia-Pacific Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 30: Acute Coronary Syndrome Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 31: Asia-Pacific Acute Coronary Syndrome Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 32: Acute Coronary Syndrome Market in Australia: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025

TABLE 33: Australian Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017

INDIA

TABLE 34: Indian Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018 to 2025

TABLE 35: Indian Acute Coronary Syndrome Historic Market Review in US$ Million: 2009-2017

SOUTH KOREA

TABLE 36: Acute Coronary Syndrome Market in South Korea: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025

TABLE 37: South Korean Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017

REST OF ASIA-PACIFIC

TABLE 38: Rest of Asia-Pacific Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 39: Acute Coronary Syndrome Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million for the Period 2009-2017

LATIN AMERICA

TABLE 40: Latin American Acute Coronary Syndrome Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 41: Acute Coronary Syndrome Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 42: Latin American Acute Coronary Syndrome Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

ARGENTINA

TABLE 43: Argentinean Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025

TABLE 44: Acute Coronary Syndrome Market in Argentina in US$ Million: A Historic Review for the Period 2009-2017

BRAZIL

TABLE 45: Acute Coronary Syndrome Market in Brazil: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 46: Brazilian Acute Coronary Syndrome Historic Market Scenario in US$ Million: 2009-2017

MEXICO

TABLE 47: Acute Coronary Syndrome Market in Mexico: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025

TABLE 48: Mexican Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017

REST OF LATIN AMERICA

TABLE 49: Rest of Latin America Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025

TABLE 50: Acute Coronary Syndrome Market in Rest of Latin America: A Historic Review in US$ Million for 2009-2017

MIDDLE EAST

TABLE 51: The Middle East Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 52: Acute Coronary Syndrome Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 53: The Middle East Acute Coronary Syndrome Market Share Breakdown by Region/Country: 2009, 2019, and 2025

IRAN

TABLE 54: Iranian Market for Acute Coronary Syndrome: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 55: Acute Coronary Syndrome Market in Iran: Historic Sales Analysis in US$ Million for the Period 2009-2017

ISRAEL

TABLE 56: Israeli Acute Coronary Syndrome Market Estimates and Forecasts in US$ Million: 2018-2025

TABLE 57: Acute Coronary Syndrome Market in Israel in US$ Million: A Historic Review for the Period 2009-2017

SAUDI ARABIA

TABLE 58: Saudi Arabian Acute Coronary Syndrome Market Growth Prospects in US$ Million for the Period 2018-2025

TABLE 59: Acute Coronary Syndrome Historic Market Analysis in Saudi Arabia in US$ Million: 2009-2017

UNITED ARAB EMIRATES

TABLE 60: Acute Coronary Syndrome Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025

TABLE 61: United Arab Emirates Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017

REST OF MIDDLE EAST

TABLE 62: Acute Coronary Syndrome Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025

TABLE 63: Rest of Middle East Acute Coronary Syndrome Historic Market Analysis in US$ Million: 2009-2017

AFRICA

TABLE 64: African Acute Coronary Syndrome Market Estimates and Projections in US$ Million: 2018 to 2025

TABLE 65: Acute Coronary Syndrome Market in Africa: A Historic Review in US$ Million for 2009-2017

IV. COMPETITION

AMGEN

ASTELLAS PHARMA, INC.

ASTRAZENECA PLC

BIOLOGICAL E.

DAIICHI SANKYO CO., LTD.

DR. REDDY'S LABORATORIES LTD.

EISAI CO.

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

GLAXOSMITHKLINE PLC

JOHNSON & JOHNSON

MOMENTA PHARMACEUTICALS

PFIZER, INC

RECORDATI SPA

THE MEDICINES COMPANY

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen
  • Astellas Pharma, Inc.
  • Astrazeneca Plc
  • Biological E.
  • Daiichi Sankyo Co., Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eisai Co.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Johnson & Johnson
  • Momenta Pharmaceuticals
  • Pfizer, Inc
  • Recordati Spa
  • the Medicines Company
Note: Product cover images may vary from those shown
Adroll
adroll